Companies you'll love to work for

1upHealth is the leading FHIR® API platform that connects an ecosystem of payers, providers, patients, life sciences and app developers within a trusted interoperability network. Unlike legacy enterprise companies, 1upHealth was created and built with the modern healthcare infrastructure in mind. The 1up FHIR® API platform is serverless with cloud-native applications that transform data at enterprise scale with greater ease and simplicity to improve patient outcomes, drive population-level analytics and enable medical innovation.

66nao provides a cloud based platform for digital brain assessment and training.

Developer of a medical device platform designed to improve the treatment of hypervascular tumours. The company is developing novel radiopaque bland embolic and beta radiation emitting radiopaque Y-90 radioembolic agents that will help to improve targeting of tumour vascularity and tumour tissue, enabling doctors to help standardize, optimize and personalize these minimally invasive therapies.

Adagene was co-founded by two serial entrepreneurs to power antibody discovery. Its aim is to become the leading player in antibody discovery and engineering. It has developed a proprietary dynamic precision library (DPL) and is showcasing the power of the library with a unique pipeline of innovative antibody therapeutics that is advancing into clinical trials. Adagene previously has raised three series of financing with over $86 million. Investors include F-Prime Capital (formerly Fidelity Biosciences), Eight Roads Ventures China (formerly Fidelity Growth Partners Asia), 6 Dimensions Capital, GP Healthcare Capital, Sequoia China, and New World TMT.

Affinia Therapeutics is an innovative gene therapy company focused on broadening the reach of gene therapy. Our proprietary Affinia Rationally-designed Therapies (ART) platform is created to address key limitations of conventional gene therapies, by developing novel capsids, novel promoters, and novel manufacturing approaches to developing gene therapies for rare and prevalent devastating diseases. We are backed by a strong syndicate of life science investors and have ambitious plans to have a dramatic impact on the lives of patients around the world.

Akrevia Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company’s proprietary Aklusion™ platform technology allows biologics to be specifically activated in the tumor microenvironment, and with precisely tailored properties, expanding the universe of natural immune-activating proteins that can be safely delivered. Akrevia is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for patients living with cancer.

AmplifyMD connects medical institutions with a lack of specialty access – often in rural or small regions of the United States – to a network of leading specialists. The company provides both the clinical team and the software to streamline and automate virtual care delivery and billing workflows and integrates seamlessly with hospitals’ existing EHRs.

Provider of digital therapeutics focused on designing and developing therapeutic virtual reality interventions. The company's platform addresses acute and chronic pain and related behavioral health issues with opioid sparing in both inpatient and outpatient settings, enabling users to increase patient experience, improving population health and reducing patient cost per capita.

Argyle provides a single global access point to employment data. From that access point, any business can process verifications, gain real-time transparency into earnings as well as view and update worker profile details. By removing the barriers between a worker, the companies they make money from, and the business they buy services and products from Argyle has reimagined how employment data can be used. Argyle was founded in 2018 and operates out of New York.

At Artemis Health, we are striving to help fix healthcare in America. We’re making it easy for self-insured employers to use their own benefits data to reduce spending and improve benefits for their employees. Because we believe that everyone should have good healthcare they can afford.